The hyperplasia suppressor gene HSG, previously characterized for its function in mitochondrial fusion, has now been identified as a novel inhibitor of the Ras signalling pathway during smooth muscle cell proliferation. Because of the critical function of this process in atherosclerotic heart disease, these findings may have important clinical implications.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The mitochondrial fusion-associated protein MFN2 can be used as a novel prognostic molecule for clear cell renal cell carcinoma
BMC Cancer Open Access 16 October 2023
-
Molecules linked to Ras signaling as therapeutic targets in cardiac pathologies
Biological Research Open Access 03 August 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Malumbres, M. & Barbacid, M. Nature Rev. Cancer. 3, 459–465 (2003). Erratum in Nature Rev. Cancer. 3, 708 (2003).
Chien, K.R. & Olson, E.N. Cell 110, 153–162 (2002).
Hoshijima, M. & Chien, K.R. J. Clin. Invest. 109, 849–855 (2002).
Olson, E.N. & Schneider, M.D. Genes Dev. 17, 1937–1956 (2003).
Chen, K.-H. et al. Nature Cell Biol. 6, 872–883 (2004).
Geiser, J.R. et al. Mol. Biol. Cell 9, 1741–1756 (1998).
Wu, C.H. et al. J. Surg. Res. 99, 100–106 (2001).
Woods, T.C. & Marks, A.R. Annu. Rev. Med. 55, 169–178 (2004).
Mann, M.J. et al. Lancet. 354, 1493–1498 (1999).
Morice, M.C. et al. N. Engl. J. Med. 346, 1773–1780 (2002).
Mintz, G.S. et al. Circulation. 108, 1295–1298 (2003).
Dzau, V.J., Braun-Dullaeus, R.C. & Sedding, D.G. Nature Med. 8, 1249–1256 (2002).
Hunter, J.J. & Chien, K.R. N. Engl. J. Med. 341, 1276–1283 (1999).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chien, K., Hoshijima, M. Unravelling Ras signals in cardiovascular disease. Nat Cell Biol 6, 807–808 (2004). https://doi.org/10.1038/ncb0904-807
Issue Date:
DOI: https://doi.org/10.1038/ncb0904-807
This article is cited by
-
The mitochondrial fusion-associated protein MFN2 can be used as a novel prognostic molecule for clear cell renal cell carcinoma
BMC Cancer (2023)
-
Molecules linked to Ras signaling as therapeutic targets in cardiac pathologies
Biological Research (2021)
-
Mitofusion 2 Overexpression Decreased Proliferation of Human Embryonic Lung Fibroblasts in Acute Respiratory Distress Syndrome through Inhibiting RAS-RAF-1-ERK1/2 Pathway
Current Medical Science (2020)
-
Mitofusin-2 over-expresses and leads to dysregulation of cell cycle and cell invasion in lung adenocarcinoma
Medical Oncology (2015)
-
Valsartan inhibits angiotensin II-induced proliferation of vascular smooth muscle cells via regulating the expression of mitofusin 2
Journal of Huazhong University of Science and Technology [Medical Sciences] (2012)